Newsletter Subject

New “Cure Computer” Breaks the Healthcare System

From

energyandcapital.com

Email Address

newsletter@energyandcapital.com

Sent On

Mon, Apr 18, 2022 01:04 PM

Email Preheader Text

It used to be the healthcare industry’s best-kept secret. But to our readers, it should be pain

It used to be the healthcare industry’s best-kept secret. But to our readers, it should be painfully obvious: Cancer is as deadly as it is profitable. It used to be the healthcare industry’s best-kept secret. But to our readers, it should be painfully obvious: Cancer is as deadly as it is profitable. [Energy and Capital logo] New “Cure Computer” Breaks the Healthcare System [Luke Sweeney Photo] By [Luke Sweeney]( Written Apr 18, 2022 Cancer sucks. Anyone who has watched a loved one suffer and fade away already knows that. But there’s something the medical industry doesn't want you to know. It used to be the healthcare industry’s best-kept secret. But to our readers, it should be painfully obvious: Cancer is as deadly as it is profitable. For our U.S. readers, this sad story should be all too familiar. The corrupt healthcare system is incredibly effective at separating the poor and sick from their money. The amount of money the industry rakes in every year is monstrous. Lifesaving drugs for some of humanity’s worst diseases earned Big Pharma giants like Pfizer and Johnson & Johnson billions. [1] Even the most conservative analysts are predicting the global health market to surge well into the trillions of dollars within a few years. Supporters of the current system (i.e., the ones making money) claim that newer drugs are far more complex, so they require more research to bring to market. This is entirely true. Stock market guru Alexander Boulden has put together a system that carefully monitors America’s elite. He’s installed motion detectors at every level of the financial system that alert him that something’s about to happen. The moment insiders make a big move behind the scenes, he can see it and make a trade before the stock takes off. The truth is that anyone can make a fortune on insider-led trades if you have access to what fast-moving tip-offs his system discovers. After years of rigorous testing, the Insider Stakeout system has proven that it’s possible to make triple-digit gains (or higher!) every single month. It levels the playing field and puts you back in control — delivering gains of 155%... 162%... 367%... 524%... all the way up to 3,041%. He’ll be introducing his system in a matter of days… [Simply click here if you’d like to get a preview of it before everyone else.]( However, the smart folks at Big Pharma have found a rather ingenious way to avoid paying their own bills... And by “ingenious” I of course mean “horrifically unethical.” The simple solution? Make YOU pay for it and then charge exorbitant prices if and when you need a prescription. It sounds like a dystopian joke, but that’s the way things are done in America. Pharmaceutical companies beg the government for billions in tax subsidies to bring a drug to market. Then, once the hard work is done, the company slaps on a 3,000% markup and begins gleefully extorting sick people. Take a look at how most of these companies use their money. It’s painfully obvious they aren't in the business of curing the sick. [2] The entire system is broken — at least for everyone who isn't making a quick buck. According to many experts, the problems may be too widespread to fix. It sounds drastic, but the only solution might be to scrap everything and start over. Early Bitcoiner Is Now All-in on THIS Christian DeHaemer was one of the first independent financial analysts to recommend Bitcoin and Ethereum... setting people up to make over $1 million with a starting stake of just a few thousand dollars. But right now, he’s tracking six tiny NEW cryptocurrencies, each of which has the potential to rise 10,000% or more in the VERY near future. Check out his urgent report on the next generation of cryptocurrencies by [clicking here NOW.]( Is That Even Possible? The economics of health care can be incredibly complicated. The U.S. in particular plays host to a dense web of admins, coders, agents, and officers whose sole function is to shuffle around money and paperwork. It’s a frustrating feature of the country’s hybrid-payer bureaucracy. Most of the world started with a multipayer system where individuals were responsible for covering their own healthcare costs within a free market of providers. Most European countries ditched the multipayer setup sometime in the late 20th century, when healthcare costs started to really take off. In an instant, all the bureaucratic bloat evaporated. Both healthcare systems have pros and cons — just ask one of the Brits waiting months for an appointment with the NHS or an American paying $3,000 for a routine surgery. My point is, regardless of whether the U.S. ever adopts a universal healthcare system, the entire industry is obsolete. "Miracle Mineral" at Center of Multi-Trillion Wealth Bonanza Inside each of these spheres is a natural resource more important than oil, coal, or gas. It’s called the “Miracle Mineral.” [See how this little-known resource could give savvy investors the chance to turn $500 into $82,175 over the next few months.]( That’s where this machine comes in. [2] It’s not a typewriter that uses blood, despite its appearance. This small device, made by a similarly small team in Maryland, is the world’s first “cure computer.” Put simply, this newly created medical tool upgrades your immune system to easily fight off some of the world’s deadliest diseases. It’s called CAR-T therapy, and it has the potential to cure every disease known to man. The entire biotech industry has been fighting tooth and nail to get exclusive access to this technology. Believe it or not, [this small-cap company]( beat out all of the rest. Scoring this patent means CAR-T therapy will be protected from the meddling hands of Big Pharma. Pfizer and Moderna will have to wait their turn. Charles Schwab, BlackRock, and Morgan Stanley have already made relatively small early investments, just to dip their toes in the water. But for now, this incredible team has flown completely under the mainstream media’s radar. It won't stay a secret for long, [so]([check out the details here, completely free of charge](. To your wealth, Luke Sweeney Contributor, Energy and Capital P.S. Are you curious about what America’s elite are up to? I hate to be the bearer of bad news, but these billionaire insiders are quietly siphoning away the biggest profits and leaving almost nothing behind for the rest of us. And unfortunately, most regular investors have no idea that these backdoor trades even exist unless you’re a part of America’s elite club of billionaires. That ends here. My colleague Alexander Boulden has spent years rigorously testing his trading system. His Insider Stakeout algorithm uses four spotlights to track what America’s wealthy are up to. It allows you to level the playing field and puts you back in control of your financial destiny. [Sign up today to be a part of Alexander’s Insider Stakeout]( and start beating the insiders at their own game. Browse Our Archives [The Chart Making Elon Musk Cry Every Night]( [The $5 Anti-Putin Energy Investment!]( [Can This Small Company Match Apple’s 200,000% Rise?]( [3 Ways to Beat a Bear Market for Big Money]( [Following in Elon Musk's Footsteps]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here]( and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Energy and Capital, please add newsletter@energyandcapital.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. Energy and Capital, Copyright © 2022, Angel Publishing LLC. All rights reserved. 3 E Read Street, Baltimore, MD 21202. Your privacy is important to us – we will never rent or sell your e-mail or personal information. Please read our [Privacy Policy](. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment advice. Read our [Details and Disclosures.](

Marketing emails from energyandcapital.com

View More
Sent On

08/12/2024

Sent On

06/12/2024

Sent On

06/12/2024

Sent On

04/12/2024

Sent On

04/12/2024

Sent On

02/12/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.